In cohort with no CVD, not receiving antiplatelet therapy, 7 percent of bleeding events were fatal
Most Bleeding Events in Non-CVD Patients Are GI-Related In cohort with no CVD, not receiving antiplatelet therapy, 7 percent of bleeding events were fatal EHS Share Facebook Twitter LinkedIn Tumblr Pinterest Reddit Messenger Messenger WhatsApp Telegram Viber Line Share via Email